Catherine Pletan

Catherine (Combot) Pletan is an experienced entrepreneur and acting Chief Development Officer/Chief Operating Officer at ULTRace, where they focus on the operational strategies and scientific oversight of novel therapeutics development. With over 25 years in the Biotech and Medtech sectors, Catherine has successfully led key strategic programs from discovery through clinical phases, contributing to regulatory achievements and significant funding initiatives. They hold a Pharm D and MSC from Université de Tours and are currently pursuing additional studies at ESSEC Business School. Catherine has also held senior roles at various companies, including GamaMabs Pharma and BrainEver, where they are responsible for R&D operations targeting neurodegenerative diseases.